Some regions statistically associated with grade III tumors in our study harbor genes either frequently amplified in aggressive breast cancer such as the oncogenes MYC (8q24) and CCNE1 (19q12) or already reported as deleted in breast tumors such as MTAP (9p21) [30]. The gene discussed is MYC; the disease is breast cancer.